GB261
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GB261, covering 2023-05-22 to 2025-09-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GB261 in Systemic Sclerosis [EARLY_Phase 1]